Publicaciones en las que colabora con Vicente Germán Casabó Alós (19)

2011

  1. A pharmacokinetic model for evaluating the impact of hepatic and intestinal first-pass loss of saquinavir in the rat

    Drug Metabolism and Disposition, Vol. 39, Núm. 2, pp. 294-301

2007

  1. Bioavailability and pharmacokinetic model for ritonavir in the rat

    Journal of Pharmaceutical Sciences, Vol. 96, Núm. 3, pp. 633-643

  2. Population modelling to describe pharmacokinetics of amiodarone in rats: Relevance of plasma protein and tissue depot binding

    European Journal of Pharmaceutical Sciences, Vol. 30, Núm. 2, pp. 190-197

2006

  1. Estudio de la interaccion entre Ritonavir y Saquinavir en su absorción intestinal

    Ciencia y Tecnologia Pharmaceutica, Vol. 16, Núm. 1, pp. 17-21

  2. Estudio de la interacción entre ritonavir y saquinavir en su absorción intestinal

    Ciencia y tecnología pharmacéutica: Revista española del medicamento y del producto sanitario, Vol. 16, Núm. 1, pp. 17-21

2005

  1. Use of nonlinear mixed effect modeling for the intestinal absorption data: Application to ritonavir in the rat

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 61, Núm. 1-2, pp. 20-26

2004

  1. Pharmacokinetic models for the saturable absorption of cefuroxime axetil and saturable elimination of cefuroxime

    European Journal of Pharmaceutical Sciences, Vol. 21, Núm. 2-3, pp. 217-223

2002

  1. Intestinal transport of cefuroxime axetil in rats: Absorption and hydrolysis processes

    International Journal of Pharmaceutics, Vol. 234, Núm. 1-2, pp. 101-111

2000

  1. Determinación de cefuroxima en plasma mediante cromatografía líquida de alta resolución (CLAR): extracción en fase sólida

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 3, pp. 71-77

  2. Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat

    International Journal of Pharmaceutics, Vol. 202, Núm. 1-2, pp. 89-96

1997

  1. Evidence of competitive inhibition of methotrexate absorption by leucovorin calcium in rat small intestine

    International Journal of Pharmaceutics, Vol. 155, Núm. 1, pp. 109-119

  2. Intestinal absorption kinetics of amiodarone in rat small intestine

    Biopharmaceutics and Drug Disposition, Vol. 18, Núm. 6, pp. 523-532

  3. Nonlinear intestinal absorption kinetics of cefuroxime axetil in rats

    Antimicrobial Agents and Chemotherapy, Vol. 41, Núm. 2, pp. 445-448

1996

  1. Evidence of competitive inhibition for the intestinal absorption of baclofen by phenylalanine

    International Journal of Pharmaceutics, Vol. 132, Núm. 1-2, pp. 63-69

  2. Interaction of taurine on baclofen intestinal absorption: A nonlinear mathematical treatment using differential equations to describe kinetic inhibition models

    Journal of Pharmaceutical Sciences, Vol. 85, Núm. 11, pp. 1248-1254

1995

  1. Effects of polysorbate 80 on amiodarone intestinal absorption in the rat

    International Journal of Pharmaceutics, Vol. 122, Núm. 1-2, pp. 1-8

  2. Influence of leucine on intestinal baclofen absorption as a model compound of neutral α‐aminoacids

    Biopharmaceutics & Drug Disposition, Vol. 16, Núm. 7, pp. 563-577

1994

  1. Effects of Surfactants on Amiodarone Intestinal Absorption. I. Sodium Laurylsulfate

    Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists, Vol. 11, Núm. 7, pp. 1042-1047

1989

  1. Evidence of a specialized transport mechanism for the intestinal absorption of baclofen

    Biopharmaceutics & Drug Disposition, Vol. 10, Núm. 3, pp. 279-297